NCT02441907View on ClinicalTrials.gov

Predictors of Treatment Response to Aflibercept and Aqueous Cytokine Levels in Diabetic Macular Edema

PHASE4CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

August 31, 2015

Primary Completion Date

August 31, 2018

Study Completion Date

September 30, 2019

Conditions
Diabetic Macular Edema
Interventions
DRUG

aflibercept

Trial Locations (1)

M5C2T2

St. Michael's Hospital Eye Clinic, Toronto

All Listed Sponsors
lead

Unity Health Toronto

OTHER

NCT02441907 - Predictors of Treatment Response to Aflibercept and Aqueous Cytokine Levels in Diabetic Macular Edema | Biotech Hunter | Biotech Hunter